Author

K. Chaitanya

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Karatt-Vellatt· 1 shared C. Tebbutt· 1 shared D. Matthews· 1 shared D. Pazeraitis· 1 shared D. Tang· 1 shared D. Tongue· 1 shared E. M. Bentley· 1 shared E. W. Masters· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Karatt-Vellatt

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintJan 14, 2021

Molecular mechanisms underlying attenuation of live attenuated Japanese encephalitis virus vaccine SA14-14-2

P. Hoovina Venkatesh, S. Kumar, N. Kumar…·V. Satchidanandam

This paper identifies molecular mechanisms of attenuation in the SA14-14-2 Japanese encephalitis vaccine strain, showing loss of NS1 and envelope protein folding defects lead to enhanced immune responses.

DOI 10.1101/2021.01.14.426643

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 29, 2020

Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence

G. Bullen, J. D. Galson, P. Villar…·A. Karatt-Vellatt

The paper identifies potent neutralising antibodies from early COVID-19 patient samples and shows high convergence in antibody sequences across studies.

DOI 10.1101/2020.12.29.424711

humanbulk RNA-seq

𝕏 PostBluesky